The cardiac stem cell compartment is indispensable for myocardial cell homeostasis, repair and regeneration in the adult

Stem Cell Research

Volumn 13, Issue 3, 2014, Pages 615-630

  Nadal Ginard, Bernardo ^a,c   Ellison, Georgina M ^a,b,c   Torella, Daniele ^b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH FACTOR; SCATTER FACTOR; SOMATOMEDIN C;

ACUTE HEART INFARCTION; ADULT; ALLOGENEIC STEM CELL TRANSPLANTATION; CARDIAC STEM CELL; CELL COMPARTMENTALIZATION; CELL CYCLE; CELL DIFFERENTIATION; CELL DIVISION; CELL FUNCTION; CELL GROWTH; CELL METABOLISM; CELL REGENERATION; CELL RENEWAL; CYTOLOGY; DISEASE SEVERITY; HEART MUSCLE; HEART MUSCLE CELL; HEART MUSCLE INJURY; HOMEOSTASIS; HUMAN; MICROVASCULATURE; MITOSIS; MUSCLE DEVELOPMENT; NONHUMAN; REGENERATIVE ABILITY; REVIEW; STEM CELL TRANSPLANTATION; TURNOVER TIME; ADULT STEM CELL; ANIMAL; GROWTH, DEVELOPMENT AND AGING; HEART; PATHOPHYSIOLOGY; REGENERATION;

ADULT STEM CELLS; ANIMALS; CELL DIFFERENTIATION; HEART; HOMEOSTASIS; HUMANS; MYOCARDIUM; REGENERATION;

EID: 84911457666     PISSN: 18735061     EISSN: 18767753     Source Type: Journal    
DOI: 10.1016/j.scr.2014.04.008     Document Type: Review

References (101)

1. Abdel-Latif A., et al. Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis. Arch. Intern. Med. 2007, 167:989-997.
2. Anversa P., Kajstura J. Ventricular myocytes are not terminally differentiated in the adult mammalian heart. Circ. Res. 1998, 83:1-14.
3. Anversa P., et al. Myocyte renewal and ventricular remodelling. Nature 2002, 415:240-243.
4. Badylak S.F., et al. Engineered whole organs and complex tissues. Lancet 2012, 379:943-952.
5. Beltrami A.P., et al. Evidence that human cardiac myocytes divide after myocardial infarction. N. Engl. J. Med. 2001, 344:1750-1757.
6. Beltrami A.P., et al. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 2003, 114:763-776.
7. Bergmann O., et al. Evidence for cardiomyocyte renewal in humans. Science 2009, 324:98-102.
8. Bersell K., et al. Neuregulin1/ErbB4 signaling induces cardiomyocyte proliferation and repair of heart injury. Cell 2009, 138:257-270.
9. Bianchi D.W., et al. Male fetal progenitor cells persist in maternal blood for as long as 27years postpartum. Proc. Natl. Acad. Sci. U. S. A. 1996, 93:705-708.
10. Bolli R., et al. Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial. Lancet 2011, 378:1847-1857.
11. Boström P., et al. C/EBPβ controls exercise-induced cardiac growth and protects against pathological cardiac remodeling. Cell 2010, 143:1072-1083.
12. Brown M.S., et al. Koch's postulates for cholesterol. Cell 1992, 71:187-188.
13. Buckingham M., et al. Skeletal muscle stem cells. Curr. Opin. Genet. Dev. 2008, 18:330-336.
14. Chien K.R. Meeting Koch's postulates for calcium signaling in cardiac hypertrophy. J. Clin. Invest. 2000, 105:1339-1342.
15. Chien K.R., et al. Converging pathways and principles in heart development and disease: CV@CSH. Cell 2002, 110:153-162.
16. Chong J.J., et al. Adult cardiac-resident MSC-like stem cells with a proepicardial origin. Cell Stem Cell 2011, 9:527-540.
17. Dauwe D.F., et al. Stem cell therapy for the treatment of myocardial infarction. Curr. Pharm. Des. 2011, 17:3328-3340.
18. Dong F., et al. Myocardial CXCR4 expression is required for mesenchymal stem cell mediated repair following acute myocardial infarction. Circulation 2012, 126:314-324.
19. Eisenberg C.A., et al. Bone marrow cells transdifferentiate to cardiomyocytes when introduced into the embryonic heart. Stem Cells 2006, 24:1236-1245.
20. Ellison G.M., et al. Acute beta-adrenergic overload produces myocyte damage through calcium leakage from the ryanodine receptor 2 but spares cardiac stem cells. J. Biol. Chem. 2007, 282:11397-11409.
21. Ellison G.M., et al. Myocyte death and renewal: modern concepts of cardiac cellular homeostasis. Nat. Clin. Pract. Cardiovasc. Med. 2007, 4(Suppl. 1):S52-S59.
22. Ellison G.M., et al. Use of heterologous non-matched Cardiac Stem Cells (CSCs) without immunosuppression as an effective regenerating agent in a porcine model of acute myocardial infarction. Eur. Heart J. 2009, 30:495. (Abstract Supplement).
23. Ellison G.M., et al. Cardiac stem and progenitor cell identification: different markers for the same cell?. Front. Biosci. 2010, 2:641-652.
24. Ellison G.M., et al. Endogenous cardiac stem cell activation by insulin-like growth factor-1/hepatocyte growth factor intracoronary injection fosters survival and regeneration of the infarcted pig heart. J. Am. Coll. Cardiol. 2011, 58:977-986.
25. Ellison G.M., et al. Physiological cardiac remodelling in response to endurance exercise training: cellular and molecular mechanisms. Heart 2012, 98:5-10.
26. pos cardiac stem cells are necessary and sufficient for functional cardiac regeneration and repair. Cell 2013, 154:827-842.
27. Evans M.J., et al. Establishment in culture of pluripotential cells from mouse embryos. Nature 1981, 292:154-156.
28. Fuchs E. The tortoise and the hair: slow-cycling cells in the stem cell race. Cell 2009, 137:811-819.
29. Gnecchi M., et al. Paracrine mechanisms in adult stem cell signaling and therapy. Circ. Res. 2008, 103:1204-1219.
30. Hatzistergos K.E., et al. Bone marrow mesenchymal stem cells stimulate cardiac stem cell proliferation and differentiation. Circ. Res. 2010, 107:913-922.
31. Hofmann M., et al. Monitoring of bone marrow cell homing into the infarcted human myocardium. Circulation 2005, 111:2198-2202.
32. Hsieh P.C., et al. Evidence from a genetic fate-mapping study that stem cells refresh adult mammalian cardiomyocytes after injury. Nat. Med. 2007, 13:970-974.
33. Huang X.P., et al. Differentiation of allogeneic mesenchymal stem cells induces immunogenicity and limits their long-term benefits for myocardial repair. Circulation 2010, 122:2419-2429.
34. Hunter J.J., et al. Signaling pathways for cardiac hypertrophy and failure. N. Engl. J. Med. 1999, 341:1276-1283.
35. Jayawardena T.M., et al. MicroRNA-mediated in vitro and in vivo direct reprogramming of cardiac fibroblasts to cardiomyocytes. Circ. Res. 2012, 110:1465-1473.
36. Jessup M., Brozena S. Heart failure. N. Engl. J. Med. 2003, 348:2007-2018.
37. Kahan B.D. Fifty years in the vineyard of transplantation: looking back. Transplant. Proc. 2011, 43:2853-2859.
38. Kajstura J., et al. Myocyte turnover in the aging human heart. Circ. Res. 2010, 107:1374-1386.
39. Kajstura J., et al. Cardiomyogenesis in the aging and failing human heart. Circulation 2012, 126:1869-1881.
40. Kawaguchi N., et al. c-kitpos GATA-4 high rat cardiac stem cells foster adult cardiomyocyte survival through IGF-1 paracrine signalling. PLoS One 2010, 5:e14297.
41. Kikuchi K., et al. Cardiac regenerative capacity and mechanisms. Annu. Rev. Cell Dev. Biol. 2012, 28:719-741.
42. Kopp J.L., et al. Progenitor cell domains in the developing and adult pancreas. Cell Cycle 2011, 10:1921-1927.
43. Kotton D.N. Next generation regeneration: the hope and hype of lung stem cell research. Am. J. Respir. Crit. Care Med. 2012, (Apr 19).
44. Koudstaal S., et al. Sustained delivery of insulin-like growth factor-1/hepatocyte growth factor stimulates endogenous cardiac repair in the chronic infarcted pig heart. J. Cardiovasc. Transl. Res. 2014, 7:232-241.
45. Kühn B., et al. Periostin induces proliferation of differentiated cardiomyocytes and promotes cardiac repair. Nat. Med. 2007, 13:962-969.
46. Laflamme M.A., et al. Heart regeneration. Nature 2011, 473:326-335.
47. Latil M., et al. Skeletal muscle stem cells adopt a dormant cell state post mortem and retain regenerative capacity. Nat. Commun. 2012, 3:903.
48. Laugwitz K.L., et al. Postnatal isl1+ cardioblasts enter fully differentiated cardiomyocyte lineages. Nature 2005, 433:647-653.
49. Loffredo F.S., et al. Bone marrow-derived cell therapy stimulates endogenous cardiomyocyte progenitors and promotes cardiac repair. Cell Stem Cell 2011, 8:389-398.
50. MacLellan W.R., et al. Overlapping roles of pocket proteins in the myocardium are unmasked by germ line deletion of p130 plus heart-specific deletion of Rb. Mol. Cell. Biol. 2005, 25:2486-2497.
51. Makkar R.R., et al. Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial. Lancet 2012, 379:895-904.
52. Malliaras K., et al. Safety and efficacy of allogeneic cell therapy in infarcted rats transplanted with mismatched cardiosphere-derived cells. Circulation 2012, 125:100-112.
53. Malliaras K., et al. Cardiomyocyte proliferation and progenitor cell recruitment underlie therapeutic regeneration after myocardial infarction in the adult mouse heart. EMBO Mol. Med. 2013, 5:191-209.
54. Martin C.M., et al. Persistent expression of the ATP-binding cassette transporter, Abcg2, identifies cardiac SP cells in the developing and adult heart. Dev. Biol. 2004, 265:262-275.
55. Matsuura K., et al. Adult cardiac Sca-1-positive cells differentiate into beating cardiomyocytes. J. Biol. Chem. 2004, 279:11384-11391.
56. Mercier F.E., et al. The bone marrow at the crossroads of blood and immunity. Nat. Rev. Immunol. 2011, 12:49-60.
57. Messina E., et al. Isolation and expansion of adult cardiac stem cells from human and murine heart. Circ. Res. 2004, 95:911-921.
58. Moretti A., et al. Multipotent embryonic isl1+ progenitor cells lead to cardiac, smooth muscle, and endothelial cell diversification. Cell 2006, 127:1151-1165.
59. Murry C.E., et al. Differentiation of embryonic stem cells to clinically relevant populations: lessons from embryonic development. Cell 2008, 132:661-680.
60. Nadal-Ginard B. Commitment, fusion and biochemical differentiation of a myogenic cell line in the absence of DNA synthesis. Cell 1978, 15:855-864.
61. Nadal-Ginard B., et al. Myocyte death, growth, and regeneration in cardiac hypertrophy and failure. Circ. Res. 2003, 92:139-150.
62. Oh H., et al. Telomerase reverse transcriptase promotes cardiac muscle cell proliferation, hypertrophy, and survival. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:10308-10313.
63. Oh H., et al. Cardiac progenitor cells from adult myocardium: homing, differentiation, and fusion after infarction. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:12313-12318.
64. Orlic D., et al. Bone marrow cells regenerate infarcted myocardium. Nature 2001, 410:701-705.
65. Porrello E.R., et al. Transient regenerative potential of the neonatal mouse heart. Science 2011, 331:1078-1080.
66. Qian L., et al. In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes. Nature 2012, 485:593-598.
67. Quaini F., et al. Chimerism of the transplanted heart. N. Engl. J. Med. 2002, 346:5-15.
68. Quevedo H.C., et al. Allogeneic mesenchymal stem cells restore cardiac function in chronic ischemic cardiomyopathy via trilineage differentiating capacity. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:14022-14027.
69. Ranganath S.H., et al. Harnessing the mesenchymal stem cell secretome for the treatment of cardiovascular disease. Cell Stem Cell 2012, 10(3):244-258.
70. Rasmussen T.L., et al. Getting to the heart of myocardial stem cells and cell therapy. Circulation 2011, 123:1771-1779.
71. Reule S., et al. Kidney regeneration and resident stem cells. Organogenesis 2011, 7:135-139.
72. Robinton D.A., et al. The promise of induced pluripotent stem cells in research and therapy. Nature 2012, 481:295-305.
73. Roger V.L., et al. American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2012 update: a report from the American Heart Association. Circulation 2012, 125:e2-e220.
74. Rountree C.B., et al. Stem cells in liver diseases and cancer: recent advances on the path to new therapies. Hepatology 2012, 55:298-306.
75. Rumyantsev P.P. Reproduction of growth and hyperplasia of cardiac muscle cells. 1991, 3:1-371. Harwood Academic Publishers, Chur, Switzerland. B.M. Carlson (Ed.).
76. Sampaolesi M., et al. Cell therapy of primary myopathies. Arch. Ital. Biol. 2005, 143:235-242.
77. Schneider J.W., et al. Reversal of terminal differentiation mediated by p107 in Rb-/- muscle cells. Science 1994, 264:1467-1471.
78. Senyo S.E., et al. Mammalian heart renewal by pre-existing cardiomyocytes. Nature 2013, 493:433-436.
79. Siddle H.V., et al. Reversible epigenetic down-regulation of MHC molecules by devil facial tumour disease illustrates immune escape by a contagious cancer. PNAS 2013, 110:5103-5108.
80. Simons B.D., et al. Stem cell self-renewal in intestinal crypt. Exp. Cell Res. 2011, 317:2719-2724.
81. Smart N., et al. De novo cardiomyocytes from within the activated adult heart after injury. Nature 2011, 474:640-644.
82. Smith R.R., et al. Regenerative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens. Circulation 2007, 115:896-908.
83. Song K., et al. Heart repair by reprogramming non-myocytes with cardiac transcription factors. Nature 2012, 485:599-604.
84. Soonpaa M.H., et al. Survey of studies examining mammalian cardiomyocyte DNA synthesis. Circ. Res. 1998, 83:15-26.
85. Srivastava D., et al. Potential of stem-cell-based therapies for heart disease. Nature 2006, 441:1097-1099.
86. Suh H., et al. Signaling in adult neurogenesis. Annu. Rev. Cell Dev. Biol. 2009, 25:253-275.
87. Takahashi K., et al. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126:663-676.
88. Takahashi K., et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007, 131:861-872.
89. Tam S.K., et al. Cardiac myocyte terminal differentiation. Potential for cardiac regeneration. Ann. N. Y. Acad. Sci. 1995, 752:72-79.
90. Terzic A., et al. Regenerative medicine advancing health care 2020. J. Am. Coll. Cardiol. 2010, 55:2254-2257.
91. Thomson J.A., et al. Embryonic stem cell lines derived from human blastocysts. Science 1998, 282:1145-1147.
92. Torella D., Rota M., Nurzynska D., Musso E., Monsen A., Shiraishi I., Zias E., Walsh K., Rosenzweig A., Sussman M.A., Urbanek K., Nadal-Ginard B., Kajstura J., Anversa P., Leri A. Cardiac stem cell and myocyte aging, heart failure, and insulin-like growth factor-1 overexpression. Circ Res. 2004, 94:514-524.
93. Torella D., et al. Resident cardiac stem cells. Cell. Mol. Life Sci. 2007, 64:661-673.
94. Uchida S., et al. Sca1-derived cells are a source of myocardial renewal in the murine adult heart. Stem Cell Rep. 2013, 1:397-410.
95. Urbanek K., et al. Intense myocyte formation from cardiac stem cells in human cardiac hypertrophy. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:10440-10445.
96. Urbanek K., et al. Myocardial regeneration by activation of multipotent cardiac stem cells in ischemic heart failure. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:8692-8697.
97. Waring C.D., Vicinanza C., Papalamprou A., Smith A.J., Purushothaman S., Goldspink D.F., Nadal-Ginard B., Torella D., Ellison G.M. The adult heart responds to increased workload with physiologic hypertrophy, cardiac stem cell activation, and new myocyte formation. Eur Heart J. 2012, (in press) [Epub ahead of print] PMID: 23100284.
98. Welsh J.S. Contagious cancer. Oncologist 2011, 16:1-4.
99. Yamanaka S. Strategies and new developments in the generation of patient-specific pluripotent stem cells. Cell Stem Cell 2007, 1:39-49.
100. Yoshida Y., et al. Recent stem cell advances: induced pluripotent stem cells for disease modeling and stem cell-based regeneration. Circulation 2010, 122:80-87.
101. Zhang R., et al. In vivo cardiac reprogramming contributes to zebrafish heart regeneration. Nature 2013, 498:497-501.